Advertisement

Ads Placeholder
Loading...

CytoDyn Inc.

CYDY•PNK
Healthcare
Biotechnology
$0.29
$0.008(2.91%)
U.S. Market opens in 5h 1m

CytoDyn Inc. (CYDY) Stock Overview

Explore CytoDyn Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap368.4M
P/E Ratio-9.51
EPS (TTM)$-0.03
ROE0.37%
Fundamental Analysis

AI Price Forecasts

1 Month$0.20
3 Months$0.39
1 Year Target$0.33

CYDY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of CytoDyn Inc. (CYDY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 60.91, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.33.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -9.51 and a market capitalization of 368.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.06%
5-Day Change
11.54%
1-Month Change
27.75%
3-Month Change
7.41%
6-Month Change
12.44%
Year-to-Date (YTD) Change
7.37%
1-Year Change
27.87%
3-Year Change
-12.15%
5-Year Change
-90.73%
All-Time (Max) Change
-55.38%

Contact Information

https://www.cytodyn.com
360 980 8524
1111 Main Street, Vancouver, WA, 98660

Company Facts

90 Employees
IPO DateDec 13, 2006
CountryUS
Actively Trading

Frequently Asked Questions